Medical Device News
Latest industry news, regulatory updates, and announcements from trusted sources.
Teledyne inks $1.1B takeover of Varex Imaging
Buying Varex will increase Teledyne’s exposure to the healthcare market. Teledyne said the companies’ imaging technologies complement each other with minimal overlap.
Read Full Article →Elevation Spine lands FDA clearance for expandable interbody fusion system
Elevation's FDA clearance for Saber-XA follows the agency's clearance of its Saber-C AVIA cervical fixation device in July. The post Elevation Spine lands FDA clearance for expandable interbody fusion…
Read Full Article →Health tech’s role in obesity to expand beyond a ‘nice-to-have’
Experts predict that DHTs such as wearables and apps will play a burgeoning role in obesity research and care, though equity concerns remain. The post Health tech’s role in obesity to expand beyond a …
Read Full Article →Alcon raises 2026 earnings growth outlook on positive Q2 results
The lion’s share of Alcon’s profits came from its surgical segment at around $1.6bn, indicative of an 8% uptick YoY. The post Alcon raises 2026 earnings growth outlook on positive Q2 results appeared …
Read Full Article →Teledyne agrees to acquire Varex Imaging for $1.1bn
Teledyne Technologies has entered a definitive agreement to purchase Varex Imaging in a cash transaction valued at nearly $1.1bn. The post Teledyne agrees to acquire Varex Imaging for $1.1bn appeared …
Read Full Article →Device firms back latest MDUFA deal, while patients want more postmarket safety
The latest agreement includes higher fees for overseas firms, hiring transparency requirements and greater use of real-world evidence.
Read Full Article →IRhythm grows heart monitoring leadership with $288M VitalConnect buy
Acquiring VitalConnect could unlock a $1 billion cardiac monitoring market that is only partly served by iRhythm’s existing devices.
Read Full Article →When does it make sense to build software instead of buy? One health system’s answer.
NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support tool to guide clinicians through treatment. Now, the institutions are commercializing the product so other health…
Read Full Article →FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
Read Full Article →